PepsiCo Faces Challenges from GLP-1 Drugs and Activist Investor Elliott
PepsiCo faces increased pressure to achieve its growth and margin objectives following the acquisition of a $4 billion stake by activist investor Elliott Investment Management. The company reports third-quarter results on October 8, with a significant focus on its North American business, where sales volumes have experienced a decline. Additionally, PepsiCo is challenged by the rising competition from GLP-1 weight-loss drugs affecting its salty snacks and sugary drinks.
CEO Ramon Laguarta is contending with elevated input costs due to geopolitical tensions and persistent inflation that impacts consumer demand. In response to Elliott's influence, PepsiCo announced plans in December 2025 to cut nearly 20% of its US product range by early 2026 and target an expansion of its core operating margin by at least 100 basis points over three years. Furthermore, the company committed to a supply chain review and board refresh.
In an effort to boost sales, PepsiCo reduced prices of products like Lay's and Doritos by up to 15% in February, while striving for productivity savings. Despite these initiatives, the core operating margin in the first half of the year was 15 basis points lower than the previous year, standing at 16.3% of revenue.
The second quarter presented mixed results, with net revenue increasing 6.4%, aided by international markets, but a 2% drop was seen in revenue at PepsiCo Foods North America, which includes Frito-Lay and Quaker. CEO Laguarta acknowledged that North American performance was weaker than anticipated, with expectations for gradual improvement through the year.
In response to the competitive landscape shaped by healthier product offerings from rivals like Kraft Heinz and Conagra Brands, PepsiCo launched new products such as Doritos Protein and SunChips Fiber. Concerns remain over its valuation, which has dropped to 10 times its EBITDA, compared to 18 times in mid-2022, while Coca-Cola has advanced ahead.
According to analysts, PepsiCo's efforts in revamping its US Frito-Lay business, through pricing adjustments, new products, and enhanced marketing, have not met expected outcomes, with flat sales and market losses. Third-quarter revenue is projected to rise by 4.3% to $24.96 billion, with adjusted earnings expected to increase by 0.21% to approximately $2.29 per share.
UBS analyst Peter Grom noted a cautious approach towards pricing adjustments in line with inflation, indicating a preference for a standard pricing strategy when volume increases from price reductions are not achieved. Neither Elliott nor PepsiCo responded to inquiries from Reuters regarding these developments.
